The company on April 10 recieved a notification from Nasdaq’s listing qualities department saying the company isn’t in compliance with the $10 million minimum stockholders’ equity requirement for listing, according to a news release.
The company has to submit a plan to regain compliance which may include an application to transger its common stock listing to the Nasdaq capital market. Surgalign plans to file documents on or before May 25 to regain compliance.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
